HOME > BUSINESS > Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya

Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya

gvk-blissBliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya.

 

Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.

Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Antifungal, Contraceptive, Laxative, Anti-haemorrhoidal and several others.

“The contract covers outpatient services for over 304,060 members. This medical cover is to be managed by AON Kenya Insurance Brokers Ltd and will benefit the principle contributor, his/her spouse and up to four children”, said the company.

“Service payments will be received by the company from AON, in advance, on a quarterly basis. Part payment for first quarter payment has been received by the company”, the company said.

The annual contract value on yearly basis are, $33.02 mln for first year, $37.15 mln for the second year and $41.23 for the third year.

The medical cover will be provided for dental, optical an on outpatient basis and for Maternity.

Follow ULTRA.news
L&T wins 500 cr building automation contract for Doha Metro One of Larsen & Toubro's units in the United Arab Emirates has won a Rs 500-cr order to supply building automation and control systems for 37 stations of the upcoming Doha Metro in Qatar, the company said.The contract involves installation, testing, integration, commissioning...
Ramco Systems wins first client in US logistics market US-based G&D Integrated has decided to implement Ramco Systems' logistics suite, the Chennai-based provider of cloud software said.The Illinois-based logistics provider has 1,000 employees at over 20 facilities across North America and represents the first logistics clien...
Ramco Systems wins big deal from Panasonic Malaysia Ramco Systems, the Chennai-based cloud services provider, has inked a "multi-million-dollar deal" with Panasonic Group of companies in Malaysia to digitize HR and Payroll operations for its nearly 20,000 employees.The contract marks a major win for the company. Typically,...
Cipla redraws Iran plans with new agreement, to invest Rs 121 cr Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran.An earlier agreement executed by the Company with the Iranian firm has been termi...
Alembic Pharmaceuticals receives FDA approval for hypertension tablets Alembic Pharmaceuticals Ltd said it received approval from the United States Food & Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.The Telmisartan and Amlodipine Tablets are equivalent to the Twynsta ta...
Ramco Systems wins Rs 53 cr contract from German logistics company Ramco Systems Ltd. said it secured a 7.3 million euro order from Schenker AG for implementing its Ramco HCM & Payroll software.Schenker AG is a German logistics company and a subsidiary of Deutsche Bahn, the German railway company.DB Logistics offers land, sea, and ai...
Lupin launches injectable iron formulations in India Pharma major Lupin Limited said it launched Iron Isomaltoside injectable iron formulation under two brand names “Isofer” and “Jilazo” in India.Lupin acquired the exclusive rights to market, distribute and sell the injectable formulation from Denmark based Pharmacosmos A/S.The...
Dr Reddy’s Labs launches osteoporosis drug in the US Dr Reddy's Laboratories Ltd said it launched raloxifene hydrochloride tablets --used to treat osteoporosis -- in the US market.Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharm...
Sun Pharma to get dengue vaccine technology from ICGEB Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue.The vaccine is targeted against all the four serotypes of Dengue virus that cause disease in humans and is being de...
Aarti Industries to return Rs 96 cr to shareholders via buyback Speciality Chemicals company Aarti Industries Ltd said it will buy back12 lakh equity shares at Rs 800 each, aggregating to Rs 96 cr.The company´s Board of Directors approved the equity shares -- representing up to 1.44% of the company's base."The public announcement sett...
Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets Marksans Pharma Ltd said the United States Food & Drug Administration has given its approval for its paricalcitol capsules -- a synthetic equivalent of Vitamin D.Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in t...
India overdependent on China for medicines – study India may have emerged as a key supplier of generic and affordable medicine for the world market, but it has an "overwhelming dependence" on China for the raw material required to produce these drugs, industry association Assocham said.Indian companies depend on China to supp...
HCC wins Rs 368 cr railway tunnel project in Manipur Hindustan Construction Company said it has won a Rs 368 crore contract from the Northeast Frontier Railway to Construct a safety tunnel between Tupul and Imphal in Manipur state in joint venture with Vaishno Cement Company Limited.This is part of the new railway line project ...
Lupin licenses taste-masking technology from Monosol for paediatric tablets Pharma Major Lupin Ltd. said its US subsidiary, Lupin Pharmaceutical Inc., has agreed to license technology from Monosol Rx to develop multiple paediatric-focused products.Lupin would develop the pediatric products utilizing MonoSol Rx’s proprietary PharmFilm drug delivery ...
Cadila to launch immunosuppressant drug in India Cadila Healthcare, a Ahmedabad headquartered pharmaceutical company owned by Zydus Group, said it has partnered with Switzerland-based global biopharmaceutical company Neovii to launch an drug to reduce the strength of the body's immune system in India.The drug named Grafalon...
Premier Explosives secures Rs 27 crore order from Bharat Dynamics Limited Premier Explosives, a Hyderabad based commercial explosives manufacturer, said it has won a Rs 27.7 crore order from Bharat Dynamics Limited for the supply of booster grains.The order will be delivered by end of June next year, said the company.Booster grains are used as ...
Almebic Pharmaceuticals receives inspection report from USFDA Alembic Pharmaceuticals Ltd., said it received an Establishment Inspection Report from the United States Food and Drug Administration for the inspection carried out at their formulation facility at Panelav, Gujarat.The FDA has the authority to inspect any establishment in whi...
Shilpa Medicare receives USFDA approval for generic bone marrow drug Shilpa Medicare Ltd said it received an approval from the United states Food & Drug Administration for Azacitidine injection.Azacitidine is used to treat myelodysplastic syndrome - a group of conditions in which the bone marrow produces blood cells that are misshapen and ...
Gayatri Projects wins Rs 926 cr order in Bihar, to be funded by Japanese company Gayatri projects, a highway infrastructure company, said it has won a Rs 926 crore four-laning project of NH 82 in Bihar to be funded by Japan International Coorporation Agency.The project will cover the Gaya-Hisua-Rajgir-Nalanda-Biharsharif route of NH 82 in Bihar, said ...
L&T wins projects for Rs 6,024 crores, 40% orders from Middle East Larsen & Toubro, a leading Indian infrastructure company, said it has won projects worth Rs 6,024 crores across various business segments, including some in the Middle East.Out of theRs 6,024 crores, Rs 2,501 crores worth of projects were from the Middle East.The peri...
FDA observations ‘primarily procedural’ – USFDA issued four observations about Cipla's manufacturing facilities in Goa after conducting an audit, the company said. Cipla has three facilities in Goa."The observations were primarily procedural in nature and the company has already responded to these observations," said...
Lupin receives FDA approval for generic Namenda XR dementia capsules Pharma Major Lupin Ltd said it received final approval from United States Food and Drug Administration for selling Memantine Hydrochloride extended-release capsules, a generic version of Allergan’s Namenda XR capsules.Namenda XR extended-release capsules are approved by the...
Cubex Tubings receives Rs 23.5 cr order from Oman Oil Tube manufacturers Cubex Tubings Ltd said it received a contract worth Rs 23.5 crores to supply Cu NI tube to Oman Oil Refineries and Petroleum Industries Company.The goods have to be supplied within 36 months."CUBEX", founded in 1979, is a producer of copper and copper b...
Kilitch Drugs to set up plant in Ethiopia Kilitch Drugs (India) Ltd said its unit Kilitch Estro Biotech Plc acquired land for the installation of a pharma plant in Ethiopia.4317.5 sq. mtrs of land was allotted at Oromia special zone by the Bureau of Rural Land and Environmental Protection, Federal Democratic Republic...
Suven Life Sciences gets two product patents in India and Japan Drug manufacturer Suven Life Sciences Ltd said it got two product patents in India and Japan for to a new compound for the treatment of disorders associated with Neurodegenerative diseases.The patents are valid through 2026-2032.The granted claims include a class of selec...